| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |